| [1] |
Yeh S, Khurana RN, Shah M, et al. Efficacy and Safety of Suprachoroidal CLS－TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial[J]. Ophthalmology, 2020, 127(7): 948-955.
|
| [2] |
Gerstel MS, Place VA. Drug delivery device: US, US3964482A[P/OL]. 1976－06－22.
|
| [3] |
Henry S, McAllister DV, Allen MG, et al. Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery[J]. Journal of Pharmaceutical Sciences, 1998, 87(8): 922-925.
|
| [4] |
Jiang J, Gill HS, Ghate D, et al. Coated microneedles for drug delivery to the eye[J]. Investigative Ophthalmology & Visual Science, 2007, 48(9): 4038-4043.
|
| [5] |
Huang HS, Schoenwald RD, Lach JL. Corneal penetration behavior of beta－blocking agents III: In vitro－in vivo correlations[J]. J Pharm Sci, 1983, 72(11): 1279-1281.
|
| [6] |
Hughes PM, Olejnik O, Chang－Lin JE, et al. Topical and systemic drug delivery to the posterior segments[J]. Adv Drug Deliv Rev, 2005, 57(14): 2010-2032.
|
| [7] |
Gaudana R, Ananthula HK, Parenky A, et al. Ocular drug delivery[J]. The AAPS journal, 2010, 12(3): 348-360.
|
| [8] |
Jiang J, Moore JS, Edelhauser HF, et al. Intrascleral Drug Delivery to the Eye Using Hollow Microneedles[J]. Pharmaceutical Research, 2009, 26(2): 395-403.
|
| [9] |
Mahadevan G, Sheardown H, Selvaganapathy P. PDMS embedded microneedles as a controlled release system for the eye[J]. Journal of Biomaterials Applications, 2012, 28(1): 20-27.
|
| [10] |
Patel SR, Lin ASP, Edelhauser HF, et al. Suprachoroidal drug delivery to the back of the eye using hollow microneedles[J]. Pharmaceutical Research, 2011, 28(1): 166-176.
|
| [11] |
Schoenwald R. Ocular drug delivery: Pharmacokinetic considerations[J]. Clin Pharmacokinet, 1990, 18(4): 255-269.
|
| [12] |
Mikkelson TJ, Chrai SS, Robinson JR. Competitive inhibition of drug－protein interaction in eye fluids and tissues[J]. Journal of Pharmaceutical Sciences, 2010, 62(12): 1942-1945.
|
| [13] |
Kompella UB, Kadam RS, Lee VH. Recent advances in ophthalmic drug delivery[J]. Ther Deliv, 2010, 1(3): 435-456.
|
| [14] |
Kansara V, Mitra AK. Evaluation of an Ex Vivo Model Implication for Carrier－Mediated Retinal Drug Delivery[J]. Current Eye Research, 2006, 31(5): 415-426.
|
| [15] |
Ranta VP, Mannermaa E, Lummepuro K, et al. Barrier analysis of periocular drug delivery to the posterior segment[J]. Journal of Controlled Release, 2010, 148(1): 42-48.
|
| [16] |
Einmahl S, Savoldelli M, D'Hermies F, et al. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye[J]. Investigative Ophthalmology and Visual Science, 2002, 43(5): 1533-1539.
|
| [17] |
Rai UDJP, Young SA, Thrimawithana TR, et al. The suprachoroidal pathway: a new drug delivery route to the back of the eye[J]. Drug Discovery Today, 2015, 20(4): 491-495.
|
| [18] |
Ínaltekin A, Bozkurt E, Kvrak Y. Factors Associated with Pain Level in Patients Receiving Intravitreal Injection[J]. J Curr Ophthalmol, 2021, 33(3): 323-329.
|
| [19] |
Gill HS, Denson DD, Burris BA, et al. Effect of microneedle design on pain in human volunteers[J]. Clin J Pain, 2008, 24(7): 585-594.
|
| [20] |
Bal SM, Caussin J, Pavel S, et al. In vivo assessment of safety of microneedle arrays in human skin[J]. European Journal of Pharmaceutical Sciences, 2008, 35(3): 193-202.
|
| [21] |
Aoyagi S, Izumi H, Isono Y, et al. Laser fabrication of high aspect ratio thin holes on biodegradable polymer and its application to a microneedle[J]. Sensors and Actuators a－Physical, 2007, 139(1-2): 293-302.
|
| [22] |
Parker ER, Rao MP, Turner KL, et al. Bulk micromachined titanium microneedles[J]. Journal of Microelectromechanical Systems, 2007, 16(2): 289-295.
|
| [23] |
Kim YC, Park J－H, Prausnitz MR. Microneedles for drug and vaccine delivery[J]. Advanced Drug Delivery Reviews, 2012, 64(14): 1547-1568.
|
| [24] |
Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery[J]. Journal of Controlled Release, 2007, 117(2): 227-237.
|
| [25] |
Kim SW, Ha BJ, Kim EK, et al. The Effect of Topical Bevacizumab on Corneal Neovascularization[J]. Ophthalmology, 2008, 115(6): e33-e38.
|
| [26] |
Kim YC, Grossniklaus HE, Edelhauser HF, et al. Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization[J]. Invest Ophthalmol Vis Sci, 2014, 55(11): 7376-7386.
|
| [27] |
Song HB, Lee KJ, Seo IH, et al. Impact insertion of transfer－molded microneedle for localized and minimally invasive ocular drug delivery[J]. J Control Release, 2015, 209: 272-279.
|
| [28] |
Khandan O, Kahook MY, Rao MP. Fenestrated microneedles for ocular drug delivery[J]. Sensors and Actuators B: Chemical, 2016, 223: 15-23.
|
| [29] |
Patel SR, Berezovsky DE, McCarey BE, et al. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye[J]. Invest Ophthalmol Vis Sci, 2012, 53(8): 4433-4441.
|
| [30] |
Chiang B, Kim YC, Edelhauser HF, et al. Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries[J]. Exp Eye Res, 2016, 145: 424-431.
|
| [31] |
Jung JH, Chiang B, Grossniklaus HE, et al. Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle[J]. J Control Release, 2018, 277: 14-22.
|
| [32] |
Gilger BC, Abarca EM, Salmon JH, et al. Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles[J]. Invest Ophthalmol Vis Sci, 2013, 54(4): 2483-2492.
|
| [33] |
Chiang B, Kim YC, Doty AC, et al. Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine－loaded poly(lactic acid) microspheres for the treatment of glaucoma[J]. Journal of Controlled Release, 2016, 228: 48-57.
|
| [34] |
Chae JJ, Jung JH, Zhu W, et al. Drug－Free, Nonsurgical Reduction of Intraocular Pressure for Four Months after Suprachoroidal Injection of Hyaluronic Acid Hydrogel[J]. Adv Sci (Weinh), 2020, 8(2): 2001908-2001908.
|
| [35] |
Olsen TW, Feng X, Wabner K, et al. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model[J]. Invest Ophthalmol Vis Sci, 2011, 52(7): 4749-4756.
|
| [36] |
Thakur RRS, Tekko IA, Al－Shammari F, et al. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery[J]. Drug Deliv Transl Re, 2016, 6(6): 800-815.
|
| [37] |
Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery[J]. Journal of Controlled Release, 2005, 104(1): 51-66.
|
| [38] |
Wang QL, Zhu DD, Chen Y, et al. A fabrication method of microneedle molds with controlled microstructures[J]. Mat Sci Eng C－Mater, 2016, 65: 135-142.
|
| [39] |
Mogusala V, Venisetty RK. Fabrication of Microneedle Molds and Polymer Based Biodegradable Microneedle Patches: A Novel Method[J]. American Journal of Drug Delivery and Therapeutics, 2015, 2: 1-12.
|
| [40] |
Than A, Liu C, Chang H, et al. Self－implantable double－layered micro－drug－reservoirs for efficient and controlled ocular drug delivery[J]. Nature Communications, 2018, 9(1): 4433.
|
| [41] |
Wu Y, Vora LK, Wang Y, et al. Long－acting nanoparticle－loaded bilayer microneedles for protein delivery to the posterior segment of the eye[J]. Eur J Pharm Biopharm, 2021, 165: 306-318.
|
| [42] |
Palakurthi NK, Correa ZM, Augsburger JJ, et al. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study[J]. J Ocul Pharmacol Ther, 2011, 27(2): 151-156.
|
| [43] |
Roy G, Galigama RD, Thorat VS, et al. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis[J]. Int J Pharm, 2019, 572: 118808.
|
| [44] |
Park S, Lee K, Kang H, et al. Single Administration of a Biodegradable, Separable Microneedle Can Substitute for Repeated Application of Eyedrops in the Treatment of Infectious Keratitis[J]. Adv Healthc Mater, 2021, 10(11): e2002287.
|
| [45] |
Cui M, Zheng M, Wiraja C, et al. Ocular Delivery of Predatory Bacteria with Cryomicroneedles Against Eye Infection[J]. Adv Sci (Weinh), 2021, 8(21): e2102327.
|
| [46] |
Donnelly RF, Singh TR, Garland MJ, et al. Hydrogel－Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery[J]. Adv Funct Mater, 2012, 22(23): 4879-4890.
|
| [47] |
Turner JG, White LR, Estrela P, et al. Hydrogel－Forming Microneedles: Current Advancements and Future Trends[J]. Macromol Biosci, 2021, 21(2): e2000307.
|
| [48] |
Amer M, Chen RK. Self－Adhesive Microneedles with Interlocking Features for Sustained Ocular Drug Delivery[J]. Macromolecular Bioscience, 2020, 20(6): 2000089.
|
| [49] |
Fang G, Yang X, Wang Q, et al. Hydrogels－based ophthalmic drug delivery systems for treatment of ocular diseases[J]. Mater Sci Eng C Mater Biol Appl, 2021, 127: 112212.
|
| [50] |
Kim YC, Edelhauser HF, Prausnitz MR. Targeted Delivery of Antiglaucoma Drugs to the Supraciliary Space Using Microneedles[J]. Investigative Ophthalmology & Visual Science, 2014, 55(11): 7387-7397.
|
| [51] |
Chehab HE, Le Corre A, Agard E, et al. Effect of Topical Pressure－Lowering Medication on Prevention of Intraocular Pressure Spikes after Intravitreal Injection[J]. European Journal of Ophthalmology, 2012, 23(3): 277-283.
|
| [52] |
Matthews A, Hutnik C, Hill K, et al. Indentation and needle insertion properties of the human eye[J]. Eye (Lond), 2014, 28(7): 880-887.
|
| [53] |
Chung SH, Mollhoff IN, Mishra A, et al. Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes[J]. Hum Gene Ther, 2021, 32(13-14): 682-693.
|
| [54] |
Matthaei M, Meng H, Bhutto I, et al. Systematic assessment of microneedle injection into the mouse cornea[J]. Eur J Med Res, 2012, 17(1): 19.
|
| [55] |
Goldstein DA. Achieving drug delivery via the suprachoroidal space: Use of the suprachoroidal space for drug delivery may achieve sustained delivery of therapeutics close to the source of retinal or choroidal pathology[J]. Retina Today, 2014, 14: 82-83.
|